Recently, De Noon et al. evaluated the MYC copy number changes in a total of 258 high-grade OS belonging to three different cohorts and identified a significant enrichment of focal amplifications in children, indicating that this gene is a major driver of this tumor, in particular in the pediatric settings [55]. The gene discussed is MYC; the disease is neoplasm.